Literature DB >> 32903991

Successful Treatment of Alopecia Areata Patches with Triamcinolone Acetonide Using MMP®: Report of 2 Cases.

Marina Barletta1, Luciana Gasques2.   

Abstract

Intralesional (IL) injection of corticosteroids is an effective treatment of alopecia areata (AA). A novel drug delivery technique that uses a tattoo machine (MMP®) has been successfully used to treat other skin disorders. We tested this technique to treat AA. We used the Cheyenne dermopigmentation machine (Anvisa 80281110016; Germany) with a 27 Magnum needle cartridge (Anvisa 80281110015) at a frequency of 70 Hz and needle depth of 1.0 mm. A triamcinolone acetonide (TAC) solution was placed in a sterile receptacle and loaded onto the cartridge by capillarity. We produced micropunctures of the skin with the medication-soaked needles until the affected area was covered by a bloody dew. Case 1: J.C.V., a male, with a diagnosis of AA in patches was treated with 1-monthly session with 2.5 mg/mL TAC delivered by MMP® (4 sessions in total). Case 2: L.M.V., a 78-year-old female with a diagnosis of AA was treated with 1-monthly session with 10 mg/mL TAC delivered by MMP® (4 sessions in total). MMP® is a novel technique that combines microneedling with drug delivery, and it could be used to deliver IL TAC to AA patients. This technique promotes a more uniform absorption of corticosteroids than traditional treatment methods of AA.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Alopecia; Alopecia areata; Steroids; Transdermal therapeutic system

Year:  2020        PMID: 32903991      PMCID: PMC7445582          DOI: 10.1159/000506314

Source DB:  PubMed          Journal:  Skin Appendage Disord        ISSN: 2296-9160


  15 in total

1.  Three-microneedle device as an effective option for intralesional corticosteroid administration for the treatment of alopecia areata.

Authors:  Taisuke Ito; Takashi Yoshimasu; Fukumi Furukawa; Motonobu Nakamura; Yoshiki Tokura
Journal:  J Dermatol       Date:  2017-06-30       Impact factor: 4.005

2.  Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures.

Authors:  A España; T Solano; E Quintanilla
Journal:  Dermatol Surg       Date:  2001-01       Impact factor: 3.398

3.  Bleomycin tattooing as a promising therapeutic modality in large keloids and hypertrophic scars.

Authors:  Farahnaz Fatemi Naeini; Jamshid Najafian; Koorosh Ahmadpour
Journal:  Dermatol Surg       Date:  2006-08       Impact factor: 3.398

Review 4.  An Overview of the Biology of Platelet-Rich Plasma and Microneedling as Potential Treatments for Alopecia Areata.

Authors:  Lauren C Strazzulla; Lorena Avila; Kristen Lo Sicco; Jerry Shapiro
Journal:  J Investig Dermatol Symp Proc       Date:  2018-01

5.  Treatment of keloids and hypertrophic scars with dermojet injections of bleomycin: a preliminary study.

Authors:  Yasemin Saray; A Tülin Güleç
Journal:  Int J Dermatol       Date:  2005-09       Impact factor: 2.736

6.  Efficacy of different concentrations of intralesional triamcinolone acetonide for alopecia areata: A systematic review and meta-analysis.

Authors:  Brittany E Yee; Yun Tong; Alina Goldenberg; Tissa Hata
Journal:  J Am Acad Dermatol       Date:  2019-12-13       Impact factor: 11.527

7.  Intralesional triamcinolone acetonide in alopecia areata amongst 62 Saudi Arabs.

Authors:  E P Kubeyinje
Journal:  East Afr Med J       Date:  1994-10

8.  Alopecia areata-successful outcome with microneedling and triamcinolone acetonide.

Authors:  Bs Chandrashekar; Vani Yepuri; Venkataram Mysore
Journal:  J Cutan Aesthet Surg       Date:  2014-01

9.  Original Method to Repigment Achromic Laser Tattoo Removal Scars.

Authors:  Samir Arbache; Dirlene Roth; Samia Trigo Arbache; Sergio Henrique Hirata
Journal:  Case Rep Dermatol       Date:  2019-05-23

10.  A randomized evaluator blinded study of effect of microneedling in androgenetic alopecia: a pilot study.

Authors:  Rachita Dhurat; Ms Sukesh; Ganesh Avhad; Ameet Dandale; Anjali Pal; Poonam Pund
Journal:  Int J Trichology       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.